Actively Recruiting

Age: 18Years - 65Years
MALE
Healthy Volunteers
NCT07459257

Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis

Led by Elazığ Mental Health and Diseases Hospital · Updated on 2026-03-09

150

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This longitudinal observational study aimed to investigate environmental, familial, and individual factors associated with psychiatric symptom severity in participants diagnosed with methamphetamine-induced psychotic disorder (MP). Participants diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) criteria was followed/will be followed prospectively for one year. Sociodemographic characteristics, treatment adherence, perceived social support, addiction-related clinical variables, insight levels, and psychotic symptoms was assessed/will be assessed monthly using standardized psychometric instruments. The study aimed to identify predictors associated with relapse-remission patterns and changes in psychiatric symptoms over a one-year follow-up period.

CONDITIONS

Official Title

Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis

Who Can Participate

Age: 18Years - 65Years
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of methamphetamine-induced psychotic disorder according to DSM-5-TR
  • Medication-free for at least one month before admission
  • Age 18 years or older and under 65 years
  • Provided informed consent
Not Eligible

You will not qualify if you...

  • Hypertension
  • Diabetes mellitus
  • Chronic kidney disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Cardiac illness
  • Severe neurological disorders
  • Immunological or systemic illness
  • Primary psychiatric disorders other than methamphetamine-induced psychotic disorder
  • Alcohol use disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Elazığ Mental Health and Diseases Hospital

Elâzığ, Elâzığ, Turkey (Türkiye), 23200

Actively Recruiting

Loading map...

Research Team

M

Mehmet Hamdi ÖRÜM, MD, Assoc. Prof., Psychiatrist

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here